Keyphrases
Drug Discovery
100%
Trypanosoma Cruzi (T. cruzi)
81%
High-throughput Screening
77%
Drug Target
66%
Small Molecules
49%
Visceral Leishmaniasis
44%
High-throughput
43%
Trypanosoma Brucei
43%
Pseudomonas Aeruginosa (P. aeruginosa)
36%
Malaria
35%
Leishmania Donovani
35%
Chagas Disease
32%
RapidFire Mass Spectrometry
31%
Cell-based
30%
High-throughput Screening Assays
30%
Muscarinic Cholinoceptor
29%
Anti-trypanosomatid Drugs
29%
Leucyl Aminopeptidase
29%
Plasmodium Falciparum
28%
Compound Library
26%
New Drugs
25%
Non-steroidal
24%
Novel Inhibitors
24%
Biochemical Characterization
24%
Ins(1,4,5)P3
24%
Progesterone Receptor
22%
Receptor Agonist
22%
Kinetoplastid
22%
Inositol 1,4,5-trisphosphate
21%
Rat Thoracic Aorta
20%
Screening Cascade
20%
Antimalarial Drugs
20%
Chagas Disease Drug Discovery
20%
Prostaglandin E Receptor
19%
Rat Cerebral Cortex
19%
Calcitonin Gene-related Peptide
19%
Cerebellar Granule Neurons
19%
Apologizing
19%
Faba
19%
Neonatal Rats
19%
Progesterone Receptor Modulators
19%
Protein Synthesis
19%
COVID-19
19%
Phenotypic Screening
19%
Cyclin-dependent Kinase 12
19%
Multiple Stages
19%
Screening Assays
19%
Axenic
19%
Leishmania Major
19%
Allosteric Inhibitor
19%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
88%
Trypanosoma Cruzi
59%
High-Throughput Screening
55%
Diseases
45%
Visceral Leishmaniasis
39%
Antimalarial Agent
39%
Chagas Disease
36%
Pharmacokinetics
32%
Trypanosoma Brucei
32%
Cholinergic Receptor
29%
Calcitonin Gene Related Peptide
29%
Cytosol Aminopeptidase
29%
Proteasome
29%
Phosphotransferase
27%
Kinetoplastida
26%
Plasmodium falciparum
24%
Pseudomonas aeruginosa
24%
Mouse Model
23%
Receptor
23%
Hexachlorophene
22%
Nitric Oxide
21%
Structure Activity Relationship
21%
Inositol 1,4,5 Trisphosphate
20%
Trypanosomatidae
20%
Prostaglandin E Receptor 4
19%
Carbachol
19%
Leishmania Major
19%
Cyclin Dependent Kinase
19%
SARS Coronavirus
19%
Phosphatidylinositide
18%
Inositol
17%
Alpha Calcitonin Gene Related Peptide
17%
Plasmodium
16%
6 Fluoro 2 [4 (Morpholinomethyl)phenyl] 4 [2 (1 Pyrrolidinyl)ethylaminomethyl]quinoline
14%
Proteinase
14%
IC50
14%
Prostanoid
13%
Acetylcholine
13%
Antimalarial Activity
13%
Arginine
12%
Antiinfective Agent
12%
Clinical Trial
12%
Repurposing
12%
Infection
12%
Protozoon
11%
Binding Site
11%
Prostaglandin E Receptor 2
11%
Inflammatory Disease
11%
Burkholderia pseudomallei
11%
Carboxamide
11%